Association between adiponectin and low-grade albuminuria is BMI-dependent in type 2 diabetes

Kidney and Blood Pressure Research

Volumn 33, Issue 5, 2010, Pages 405-410

  Pongrac Barlovic, Drazenka ^a   Zaletel, Jelka ^a   Prezelj, Janez ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Adiponectin; Albuminuria; Diabetes; Insulin resistance; Obesity

Indexed keywords

ADIPONECTIN; ALBUMIN; CHOLESTEROL;

ADULT; ALBUMINURIA; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; AGED; ALBUMINURIA; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; OVERWEIGHT; RISK FACTORS;

EID: 78049380565     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318292     Document Type: Article

References (30)

1. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adi-ponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
2. Stefan N, Vozarova B, Funahashi T, et al: Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002; 51: 1884-1888.
3. Yamauchi T, Kamon J, Waki H, et al: Globular adiponectin protected ob/ob mice from diabetes and apo-E-deficient mice from atherosclerosis. J Biol Chem 2003; 278: 2461-2468.
4. Kumada M, Kihara S, Ouchi N, et al: Adipo-nectin specifically increased tissue inhibitor of metalloproteinase-1 through interleu-kin-10 expression in human macrophages. Circulation 2004; 109:2046-2049.
5. Kumada M, Kihara S, Sumitsuji S, et al: Association of hypoadiponectinaemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
6. Zoccali C, Mallamaci F, Tripepi G, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141. (Pubitemid 34042020)
7. Pilz S, Mangge H, Wellnitz B, et al: Adipo-nectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006; 91:4277-4286.
8. De Zeueuw D, Parving HH, Henning RH, et al: Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17:2100-2105.
9. Wachtell K, Wachtell K, Ibsen H, et al: Albu-minuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139: 901-906.
10. Zoccali C, Mallamaci F, Panuccio V, et al: Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 2003; 63(suppl 84):98-102.
11. Looker H, Krakoff J, Funahashi T, et al: Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89:4010-4017.
12. Tsioufis C, Dimitriadis K, Chatzis D, et al: Relation of microalbuminuria to adiponec-tin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96:946-951. (Pubitemid 41362518)
13. Barlovic DP, Zaletel J, Prezelj J: Adipocytokines are associated with renal function in patients with normal range glomerular filtration range and type 2 diabetes. Cytokine 2009; 46:142-145.
14. Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20:1595-1599.
15. Sharma K, Ramachandrarao S, Qiu G, et al: Adiponectin regulates albuminuria and podocyte function in mice. J Clin Investig 2008; 118:1645-1656.
16. DeCosmo S, Minenna A, Ludovico O, et al: Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28:910-915.
17. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: 214-223.
18. Kubota N, Tearuchi Y, Yamauchi T, et al: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277: 25863-25866.
19. Matsuda M, Shimomura I, Sata M, et al: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-37491.
20. Pischon T, Girman CJ, Hotamisligil GS, et al: Plasma adiponectin levels and risk of myo-cardial infarction in men. JAMA 2004; 291: 1730-1737.
21. Menon V, Li L, Wang X, Greene T, et al: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2599-2606. (Pubitemid 44300977)
22. De Zeueuw D, Parving HH, Henning RH, et al: Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17:2100-2105.
23. Guebre-Egziabher F, Bernhard J, Funahashi T, et al: Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005; 20:129-134.
24. Malyszko J, Malyszko JS, Brzosko S, et al: Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dia-lyzed patients. J Clin Endocrinol Metab 2004; 89:4620-4627.
25. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, et al: Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 2007; 27: 1910-1917.
26. Koshimura J, Fujita H, Narita T, et al: Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 2004; 316: 165-169.
27. Yano Y, Hoshide S, Ishikawa J, et al: Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens (Greenwich) 2007; 9: 775-782.
28. Okamoto Y, Arita Y, Nishida M, et al: Anadipocyte-derived plasma protein, adiponec-tin, adheres to injured vascular walls. Horm Metab Res 2000; 32:47-50.
29. Kojima S, Funahashi T, Sakamoto T, et al: The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardialinfarction. Heart 2003; 89: 667-668.
30. Fernandez-Real JM, Castro A, Vazquez G, et al: Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 2004; 27: 739-745.